The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
MEDMIX Systems AG has developed a delivery system for the use with standard single syringes to handle multi-component biomaterials such as tissue-...
read more
3M Drug Delivery Systems announces the expansion of the pressurized metered dose inhaler (pMDI) fill line at its facility in Northridge, Calif., ...
read more
DUSA Pharmaceuticals, Inc.(R) (Nasdaq:DUSA), a dermatology company that is developing and marketing its Levulan(R) Photodynamic Therapy (PDT) platform...
read more
Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, announced today the ...
read more
IntelGenx Corp. (TSX-V:IGX) (OTCBB:IGXT) ("IntelGenx") today announced the commencement of a pivotal bioequivalence clinical trial with its anti-...
read more
Genta Incorporated (OTCBB:GNTA) announced today the appointments of Dr. Brian Leyland-Jones and Richard J. Moran, as members of the Company's Board of...
read more
Aptalis Pharmatech, Inc. (previously known as
Eurand, Inc.) and Cephalon, Inc. a wholly-owned subsidiary of Teva Pharmaceuticals Industries
Ltd, and...
read more
Wednesday, April 25, 2012
Repligen Corporation (Nasdaq:RGEN) today announced positive results from a Phase 1 study to evaluate the pharmacokinetic (PK) and safety profile of ...
read more
Wednesday, April 25, 2012
Donald E. Morel, Jr. Ph.D., chairman and CEO of West Pharmaceutical Services, Inc. (NYSE: WST), and Scottsdale Mayor W.J. “Jim” Lane will host ...
read more
AstraZeneca (NYSE: AZN) and The Medicines Company (NASDAQ: MDCO) announced today a global collaboration for acute ischemic heart disease compounds. ...
read more
Apricus Biosciences, Inc.
("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), announced today that the Company received an ...
read more
Particle size is a critical parameter for inhaled drugs, with a defining influence on deposition behavior in the lung. Particle characterization ...
read more
When Sanofi was looking to expand its popular paracetamol brand in France, they turned to Capsugel, the world’s leading provider of innovative dosage ...
read more
Catalent Pharma Solutions recently signed a definitive agreement to sell its U.S. commercial packaging operations based in Philadelphia, PA and ...
read more
Quintiles today issued the first of three white papers on the expanding role of modeling and simulation across the drug development lifecycle. “...
read more